Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Geref
2. Ghrh(1-29)nh2
3. Grf(1-29)nh2
4. Growth Hormone-releasing Factor(1-29)amide
5. Hghrh(1-29)nh2
6. Sermorelin
7. Somatotropin-releasing-hormone(1-29)amide
1. 114466-38-5
2. Ghrh (1-29)
3. Geref
4. Sermorelin Acetate [usan]
5. 114466-38-5 (acetate); 86168-78-7 (free Base).
6. H-tyr-ala-asp-ala-ile-phe-thr-asn-ser-tyr-arg-lys-val-leu-gly-gln-leu-ser-ala-arg-lys-leu-leu-gln-asp-ile-met-ser-arg-nh2
7. Unii-00ibg87iqw
8. 00ibg87iqw
9. Growth Hormone-releasing Factor (human)-(1-29)-peptide Amide, Acetate (salt), Hydrate
10. Sermorelin Acetateghrh (1-29)
11. Akos025311435
12. Somatoliberin (human Pancreatic Islet), 29-l-argininamide-30-de-l-glutamine-31-de-l-glutamine-32-deglycine-33-de-l-glutamic Acid-34-de-l-serine-35-de-l-asparagine-36-de-l-glutamine-37-de-l-glutamic Acid-38-de-l-arginine-39-deglycine-40-de-l-alanine-41-de-l-arginine-42-de-l-alanine-43-de-l-arginine-44-de-l-leucinamide-, Acetate (salt), Hydrate
13. 68s787
14. Ghrh (1-29);growth Hormone Releasing Factor Fragment 1-29 Amide Human
Molecular Weight | 3417.9 g/mol |
---|---|
Molecular Formula | C151H250N44O44S |
Hydrogen Bond Donor Count | 53 |
Hydrogen Bond Acceptor Count | 51 |
Rotatable Bond Count | 118 |
Exact Mass | 3416.8431834 g/mol |
Monoisotopic Mass | 3415.8398286 g/mol |
Topological Polar Surface Area | 1510 Ų |
Heavy Atom Count | 240 |
Formal Charge | 0 |
Complexity | 7670 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 31 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
About the Company : JIN DUN Medical Research Institute is affiliated to Shanghai JIN DUN Industrial Co., Ltd., headquartered in Shanghai, adjacent to Hongqiao High-speed Railway Station and Hongqiao I...
Market Place
ABOUT THIS PAGE
A Sermorelin Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sermorelin Acetate, including repackagers and relabelers. The FDA regulates Sermorelin Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sermorelin Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sermorelin Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sermorelin Acetate supplier is an individual or a company that provides Sermorelin Acetate active pharmaceutical ingredient (API) or Sermorelin Acetate finished formulations upon request. The Sermorelin Acetate suppliers may include Sermorelin Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Sermorelin Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sermorelin Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sermorelin Acetate active pharmaceutical ingredient (API) in detail. Different forms of Sermorelin Acetate DMFs exist exist since differing nations have different regulations, such as Sermorelin Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sermorelin Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Sermorelin Acetate USDMF includes data on Sermorelin Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sermorelin Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sermorelin Acetate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sermorelin Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sermorelin Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sermorelin Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sermorelin Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sermorelin Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sermorelin Acetate suppliers with NDC on PharmaCompass.
Sermorelin Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sermorelin Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sermorelin Acetate GMP manufacturer or Sermorelin Acetate GMP API supplier for your needs.
A Sermorelin Acetate CoA (Certificate of Analysis) is a formal document that attests to Sermorelin Acetate's compliance with Sermorelin Acetate specifications and serves as a tool for batch-level quality control.
Sermorelin Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Sermorelin Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sermorelin Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sermorelin Acetate EP), Sermorelin Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sermorelin Acetate USP).
LOOKING FOR A SUPPLIER?